To determine the efficacy and safety of transplanting HCV positive kidney allografts to HCV sero-negative patients who are on the waiting list.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
31
A HCV negative or previously successfully treated recipient with a HCV positive kidney graft
Loma Linda University Health-Transplant Institute
Loma Linda, California, United States
1-year graft and patient survival
Will track subjects post transplant for 12 months
Time frame: From the date of transplant through the last day of 12 month post transplant
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.